AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| SCT | Ann: Director Retirement - Mark Waller | 24/04/18 | 0 | 2 | |||
|
|||||||
| SCT | Ann: Completion of Business Acquisition - Alvey Group | 24/04/18 | 0 | 2 | |||
|
|||||||
| SCT | Ann: Volume Weighted Average Price - Dividend Reinvestment Plan | 23/04/18 | 0 | 19 | |||
|
|||||||
| SCT | Ann: Company Update April 2018 | 09/04/18 | 0 | 29 | |||
|
|||||||
| SCT | Ann: 2018 Interim Dividend | 14:09 | 0 | 25 | |||
|
|||||||
| SCT | Ann: 2018 Half Year Result | 14:01 | 0 | 33 | |||
|
|||||||
See All Discussions
NZX News